Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation

Artificial Organs

Volumn 39, Issue 7, 2015, Pages 569-575

  Restle, David J ^a   Zhang, David M ^a   Hung, George ^a   Howard, Jessica L ^a   Kallel, Faouzi ^b   Acker, Michael A ^a   Atluri, Pavan ^a   Bartoli, Carlo R ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b THORATEC CORPORATION   (United States)

Author keywords

Bleeding; Blood trauma; Heart failure; Left ventricular assist device; Mechanical circulatory support; Shear stress; Von Willebrand factor

Indexed keywords

ELECTROPHORESIS; FIBER OPTIC SENSORS; LEFT VENTRICULAR ASSIST DEVICES; SHEAR STRESS;

BLEEDINGS; BLOOD TRAUMA; CIRCULATORY LOOP; HEART FAILURE; IN-VITRO; MECHANICAL CIRCULATORY SUPPORT; MULTIMERS; SIMPLE++; VON WILLEBRAND FACTOR; WHOLE BLOOD;

GLYCOPROTEINS;

VON WILLEBRAND FACTOR;

ADVERSE EFFECTS; CHEMISTRY; HEART ASSIST DEVICE; HEMORRHAGE; HUMAN; MECHANICAL STRESS; METABOLISM; PROTEIN DEGRADATION; PROTEIN MULTIMERIZATION;

HEART-ASSIST DEVICES; HEMORRHAGE; HUMANS; PROTEIN MULTIMERIZATION; PROTEOLYSIS; STRESS, MECHANICAL; VON WILLEBRAND FACTOR;

EID: 84934280122     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12428     Document Type: Article

References (12)

1. Bartoli CR, Giridharan GA, Litwak KN, etal. Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricle. ASAIO J 2010;56:410-416.
2. Birschmann I, Dittrich M, Eller T, etal. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices. J Heart Lung Transplant 2014;33:80-87.
3. Islam S, Cevik C, Madonna R, etal. Left ventricular assist devices and gastrointestinal bleeding: a narrative review of case reports and case series. Clin Cardiol 2013;36:190-200.
4. Bartoli CR, Ailawadi G, Kern JA. Diagnosis, nonsurgical management, and prevention of LVAD thrombosis. J Card Surg 2014;29:83-94.
5. Bartoli CR, Restle DJ, Zhang DM, Acker MA, Atluri P. von Willebrand factor degradation with an LVAD occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage. J Thorac Cardiovasc Surg 2014; In Press.
6. Bartoli CR, Dassanayaka S, Brittian KR, etal. Insights into the mechanism(s) of von Willebrand factor degradation during mechanical circulatory support. J Thorac Cardiovasc Surg 2014;147:1634-1643.
7. Dassanayaka S, Slaughter MS, Bartoli CR. Mechanistic pathway(s) of acquired von Willebrand syndrome with a continuous-flow ventricular assist device: in vitro findings. ASAIO J 2013;59:123-129.
8. Salek MM, Sattari P, Martinuzzi RJ. Analysis of fluid flow and wall shear stress patterns inside partially filled agitated culture well plates. Ann Biomed Eng 2012;40:707-728.
9. Fraser KH, Zhang T, Taskin ME, Griffith BP, Wu ZJ. A quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index. J Biomech Eng 2012;134:081002.
10. Bartoli CR, Dowling RD. The future of adult cardiac assist devices: novel systems and mechanical circulatory support strategies. Cardiol Clin 2011;29:559-582.
11. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998;67:395-424.
12. Heilmann C, Geisen U, Beyersdorf F, etal. Acquired von Willebrand syndrome is an early-onset problem in ventricular assist device patients. Eur J Cardiothorac Surg 2011;40:1328-1333, discussion 1233.